Director and Senior Staff Specialist Hunter New England Local Health District Drug & Alcohol Clinical Services
Newcastle NSW, Australia
Dr Adrian Dunlop MBBS GdipEpiBiostat (Melb) PhD (UNSW) FAChAM CF https://www.newcastle.edu.au/profile/a-dunlop is Director and Senior Staff Specialist for Hunter New England Local Health District Drug & Alcohol Clinical Services and Conjoint Professor, School of Medicine and Public Health, Faculty of Health, University of Newcastle. He has appointments as an Honorary Medical Officer in Addiction Medicine, to the Justice Health and Forensic Mental Health Network and to the Lower Mid North Coast Local Health District, and is a consultant to the Drug & Alcohol Specialist Advisory Service (DASAS), St Vincent’s Local Health Network. He was the Chief Addiction Medicine Specialist, NSW Health (2014-2018) and Clinical Advisor (2012-13) responsible for policy advice in drug and alcohol to the NSW Ministry of Health.
He is a Foundation Fellow of the Australasian Chapter of Addiction Medicine (FAChAM) and current President-Elect of the Chapter Committee, Royal Australasian College of Physicians, Past-President of the Australasian Professional Society on Alcohol and other Drugs (APSAD), member of the College of Problems on Drug Dependence (USA), American Society of Addiction Medicine (USA), Society for the Study of Addiction (UK), and Fellow of the International Society for Addiction Medicine (FISAM). He is a Board Member for the National Clinical Centre for Research on Emerging Drugs (2017-).
In 2005 he was awarded a Churchill Fellowship to investigate the treatment of opiate dependence in pregnancy, In 2010 he was awarded Clinical Leader of the Year by HNELHD and in 2020 was a finalist for HNELHD’s Collaborative Leader of the Year award. In 2014 he was awarded the APSAD Clinician Award, in 2019 the APSAD Senior Scientist Award and was a 2015 James Rankin APSAD orator.
He has 28 years-experience in the drug and alcohol field, over 320 publications including 150 peer reviewed journal articles, 9 book chapters, a co-author on 9 Australian guidelines on drug and alcohol treatment management, including the Clinical Guidelines for the Use of Depot Buprenorphine (Buvidal and Sublocade) in the treatment of opioid dependence, funded by NSW Health. He collaborates with various drug and alcohol clinical research groups and clinical sites state across NSW and Australia and is a foundation member of the NSW Drug and Alcohol Clinical Research Network, a collaboration of NSW public sector D&A Services engaged in clinical research.